Jump to content

Innovative treatment goes into Phase II trial in US


PressWatch

Recommended Posts

Infinity Pharmaceuticals (a smallish biotech company in Cambridge, Massachussetts) has a compound - IPI-926 - which, combined with gemcitabine, is going into Phase II clinical trials for pancreatic cancer.


http://www.news-medical.net/.../Infinity-Pharmaceuticals-initiates-Phase-1b2-trial-of-IPI-926-Hedgehog-pathway-inhibitor-for-pancreatic-cancer.aspx


Apparently this material caused quite a stir when announced at a conference earlier this year. The material is claimed to inhibit regrowth of tumour cells after treatment with Gemcitabine.


Presswatch

Link to comment
Share on other sites

''The scientists found.........that pancreatic cancer is resistant to chemotherapy because the tumours tend to have poor networks of blood vessels called vasculature, which makes it harder for drugs to reach the tumour.''


Tuveson now developing new testing models.


Presswatch

Link to comment
Share on other sites

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. By using our forums you agree to our Terms of Use and Privacy Policy.